(Reuters) -Shares of Gilead rose 3% after the U.S. Supreme Court on Friday upheld a federal mandate that requires health ...

Shares of Gilead Sciences Inc. GILD rose 1.60% to $107.62 Thursday, on what proved to be an all-around great trading session ...

Gilead Sciences (GILD) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...

The agency removed some onerous requirements for the complex cancer drugs and reduced restrictions on patients’ ...

A new building of condominiums — including three affordable units — has been proposed for Brighton Center. Biotech's Future - ...

An injection that can prevent HIV infection for six months has been approved by the US Food and Drug Administration (FDA).

The high court found that members of a task force that determines what preventive drugs must be covered can be removed at ...

Merck announced ACIP voted to recommend Enflosnia (clesrovimab-cfor) as a treatment option for RSV in infants younger than 8 months of age who are born during or entering their first RSV season.

The Israeli strategist Yehoshafat Harkabi once observed that in military doctrine, the enemy is a target to destroy, but in ...

Restricted availability under an FDA-mandated drug safety program has limited the reach of CAR-T cell therapies for certain blood cancers—until now. | The FDA has removed the REMS requirements for ...

A Fierce Pharma Marketing review of the LinkedIn and Instagram pages of the 20 largest pharmas found that, as of Thursday, ...

Yeztugo (lenacapavir) will be the first option that gives people who need or want PrEP the option of injecting only twice a ...